Клинико-морфологические особенности изменений сердечно-сосудистой системы у больных COVID-19

Зумрад Эргашева

doi:10.47689/2181-3663-vol4-iss4-pp27-32

Zumrad Ergasheva Candidate of Medical Sciences, Associate Professor, Head of the Department of Internal Medicine, Andijan State Medical Institute

DOI

https://doi.org/10.47689/2181-3663-vol4-iss4-pp27-32

Keywords

COVID-19 , cardiovascular system , morphological changes , myocarditis , thrombosis

Abstract

This article examines the clinical and morphological features of cardiovascular lesions in patients with COVID-19. Pathological changes identified during postmortem examination and clinical observation of infected patients are analyzed. Particular attention is paid to mechanisms of damage to the myocardium, vascular walls, and endothelium, as well as to the development of inflammation and thrombosis. The findings underscore the importance of a comprehensive approach to diagnosing and treating cardiovascular complications in patients with COVID-19, which can help reduce mortality and improve prognosis.

References

Chistyakova, M. V., Zaitsev, D. N., Govorin, A. V., Medvedeva, N. A., & Kurokhtina, A. A. (2021). Post-COVID-19 syndrome: morpho-functional abnormalities of the heart and arrhythmias. Russian Journal of Cardiology, 26(7), 4485.

Vorobeva, O. V., & Lastochkin, A. V. (2020). Organ-specific pathomorphological changes during COVID-19. Russian Journal of Infection and Immunity, 10(3), 587-590.

Fox, S. E., Li, G., Akmatbekov, A., Harbert, J. L., Lameira, F. S., Brown, J. Q., & Vander Heide, R. S. (2020). Unexpected features of cardiac pathology in COVID-19 infection. Circulation, 142(11), 1123-1125.

Cimmino, G., D’Elia, S., Morello, M., Titolo, G., Luisi, E., Solimene, A., ... & Golino, P. (2025). Cardio-Pulmonary Features of Long COVID: From Molecular and Histopathological Characteristics to Clinical Implications. International Journal of Molecular Sciences, 26(16), 7668.

Коган Е.А., Березовский Ю.С., Благова О.В., Куклева А.Д., Богачева Г.А., Курилина Э.В., Калинин Д.В., Багдасарян Т.Р., и др. Миокардит у пациентов с COVID-19, подтвержденный результатами иммуногистохимического исследования. Кардиология. 2020;60(7):4-10 [Kogan E.A., Berezov-skiy Yu.S., Blagova O.V., Kukleva A.D., Bogacheva G.A., Kurilina E.V., Kalinin D.V., Bagdasaryan T.R., et al. Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical. Kardiologiia. 2020;60(7):4-10 (in Russ.)]. DOI: 10.18087/cardio.2020.7.n1209.

Vasichkina, E., Alekseeva, D., Karev, V., Podyacheva, E., Kudryavtsev, I., Glushkova, A., ... & Starshinova, A. (2022). Cardiac involvement in children affected by COVID-19: clinical features and diagnosis. Diagnostics, 13(1), 120.

Сережина Е.К., Обрезан А.Г. Патофизиологические механизмы и нозологические формы сердечно-сосудистой патологии при COVID-19. Кардиология. 2020;60(8):23-26 [Serezhina E.K., Obre-zan A.G. Cardiovascular Pathology in Patients With COVID-19. Kardiologiia. 2020;60(8):23-26. (in Russ.)]. DOI: 10.18087/cardio.2020.8.n1215.

Bhatla A., Mayer M. M., Adusumalli S., Hyman M. C., Oh E., Tierney A., Moss J., Chahal A. A., et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439-1444.

DOI: 10.1016/j.hrthm.2020.06.016.

Gawalko M., Kaplon-Cieslicka A., Hohl M., Do-brev D., Linz D. COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc. 2020;30:100631. DOI: 10.1016/j.ijcha.2020.100631.

Chen C., Zhou Y., Wang D. W. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;45(3):230-232. DOI: 10.1007/s00059-020-04909-z.

Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. DOI: 10.7861/clinmed.2020-0896.

Бубнова М.Г., Аронов Д.М. COVID-19 и сердечнососудистые заболевания: от эпидемиологии до реабилитации. Пульмонология. 2020;30(5):688-699 [Bubnova M.G., Aronov D.M. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonologiya. 2020;30(5):688-699 (in Russ.)]. DOI: 10.18093/0869-0189-2020-30-5-688-699.

Blagova O., Ainetdinova D.H. Lutokhina Y.A., Novo-sadov V.M., Rud' R.S., Zaitsev A.Y.U., Kukleva A.D., Alexandrova S.A., et al. Post-COVID myocarditis diagnosed by endomyocardial biopsy and/or magnetic resonance imaging 2-9 months after acute COVID-19. European Heart Journal. 2021;42:ehab724.1751. DOI: 10.1093/eurheartj/ehab724.1751.

Downloads

PDF (Русский)

6 4

Published

2025-10-20

How to Cite

Ergasheva, Z. 2025. Clinical and Morphological Characteristics of Cardiovascular System Changes in COVID-19 Patients. Preventive Medicine and Health. 4, 4 (Oct. 2025), 27–32. DOI:https://doi.org/10.47689/2181-3663-vol4-iss4-pp27-32.